At the CES 2022, Abbott Chairman and Chief Executive Officer Robert B Ford announced that Abbott is developing Lingo, a new category of consumer bio wearables.
These biowearables are being designed to translate the body’s unique language into actionable data to help customers track and measure their general health and wellness.
The sensor technology is being designed to track critical signals in the body such as glucose, ketones and lactate, and could also be used one day to track alcohol levels. Lingo extends the Abbott sensing technology platform that Abbott pioneered in 2014 for people with diabetes, allowing people to continuously monitor their glucose levels with a small sensor on the back of the upper arm.
Also Read: It’s All About Data Analytics
“Technology gives us the power to digitise, decentralise and democratise healthcare, create a shared language between you and your doctor, and put more control of your health in your hands. We’re creating a future that will bring you and your loved ones care that’s more personal and precise. It’s happening right now. And its potential is no less than incredible,” Ford said.
Abbott is designing Lingo to measure other biomarkers beyond glucose in the future. A ketone bio wearable is being developed to track ketones continuously, see how fast you are getting into ketosis, and understand exactly what keeps you there by providing insights on dieting and weight loss. A lactate bio wearable is in development to track continuous lactate build up during exercise, which can be used to indicate athletic performance.
